NO841993L - Immunologiske metoder for paavisning av maligne celler med metastatisk celleaktivitet, samt preparater for utfoerelse av slike metoder - Google Patents
Immunologiske metoder for paavisning av maligne celler med metastatisk celleaktivitet, samt preparater for utfoerelse av slike metoderInfo
- Publication number
- NO841993L NO841993L NO841993A NO841993A NO841993L NO 841993 L NO841993 L NO 841993L NO 841993 A NO841993 A NO 841993A NO 841993 A NO841993 A NO 841993A NO 841993 L NO841993 L NO 841993L
- Authority
- NO
- Norway
- Prior art keywords
- type
- antibody
- antigen
- collagenase
- enzyme
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 43
- 230000001900 immune effect Effects 0.000 title claims description 15
- 230000000694 effects Effects 0.000 title claims description 13
- 238000002360 preparation method Methods 0.000 title claims description 12
- 230000001394 metastastic effect Effects 0.000 title claims description 11
- 206010061289 metastatic neoplasm Diseases 0.000 title claims description 9
- 238000001514 detection method Methods 0.000 title description 3
- 239000000427 antigen Substances 0.000 claims description 62
- 102000036639 antigens Human genes 0.000 claims description 62
- 108091007433 antigens Proteins 0.000 claims description 62
- 102000029816 Collagenase Human genes 0.000 claims description 59
- 108060005980 Collagenase Proteins 0.000 claims description 59
- 229960002424 collagenase Drugs 0.000 claims description 29
- 102000004190 Enzymes Human genes 0.000 claims description 26
- 108090000790 Enzymes Proteins 0.000 claims description 26
- 229940088598 enzyme Drugs 0.000 claims description 26
- 230000003211 malignant effect Effects 0.000 claims description 11
- 238000000746 purification Methods 0.000 claims description 7
- 239000000523 sample Substances 0.000 claims description 7
- 102000004266 Collagen Type IV Human genes 0.000 claims description 6
- 108010042086 Collagen Type IV Proteins 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 5
- 102000035195 Peptidases Human genes 0.000 claims description 4
- 108091005804 Peptidases Proteins 0.000 claims description 4
- 239000012472 biological sample Substances 0.000 claims description 4
- 239000000969 carrier Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- 229940079919 digestives enzyme preparation Drugs 0.000 claims 3
- 238000002967 competitive immunoassay Methods 0.000 claims 1
- 235000019833 protease Nutrition 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 43
- 210000001519 tissue Anatomy 0.000 description 23
- 206010028980 Neoplasm Diseases 0.000 description 12
- 210000004881 tumor cell Anatomy 0.000 description 11
- 238000002965 ELISA Methods 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 10
- 239000002953 phosphate buffered saline Substances 0.000 description 10
- 201000011510 cancer Diseases 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 206010006187 Breast cancer Diseases 0.000 description 7
- 208000026310 Breast neoplasm Diseases 0.000 description 7
- 239000002609 medium Substances 0.000 description 6
- 210000002469 basement membrane Anatomy 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 238000012744 immunostaining Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- 201000008808 Fibrosarcoma Diseases 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 206010027476 Metastases Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241001529936 Murinae Species 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 201000008275 breast carcinoma Diseases 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 102000001938 Plasminogen Activators Human genes 0.000 description 2
- 108010001014 Plasminogen Activators Proteins 0.000 description 2
- 241000276498 Pollachius virens Species 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 210000000448 cultured tumor cell Anatomy 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 210000004754 hybrid cell Anatomy 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 229940127126 plasminogen activator Drugs 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- -1 "Bio-Gel A" 0.5 m Chemical compound 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101000958664 Homo sapiens Nucleus accumbens-associated protein 1 Proteins 0.000 description 1
- 101000631760 Homo sapiens Sodium channel protein type 1 subunit alpha Proteins 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 102000007547 Laminin Human genes 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 102100037369 Nidogen-1 Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 102100028910 Sodium channel protein type 1 subunit alpha Human genes 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 210000000628 antibody-producing cell Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 108010008217 nidogen Proteins 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 239000004017 serum-free culture medium Substances 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 150000004992 toluidines Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
- C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
- G01N2474/20—Immunohistochemistry assay
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/496,230 US4677058A (en) | 1983-05-19 | 1983-05-19 | Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO841993L true NO841993L (no) | 1984-11-20 |
Family
ID=23971775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO841993A NO841993L (no) | 1983-05-19 | 1984-05-18 | Immunologiske metoder for paavisning av maligne celler med metastatisk celleaktivitet, samt preparater for utfoerelse av slike metoder |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4677058A (pt) |
| JP (1) | JPS602187A (pt) |
| AU (1) | AU2808784A (pt) |
| BE (1) | BE899663A (pt) |
| CA (1) | CA1230052A (pt) |
| CH (1) | CH668838A5 (pt) |
| DD (1) | DD251208A5 (pt) |
| DE (1) | DE3418625A1 (pt) |
| DK (1) | DK243184A (pt) |
| ES (1) | ES8605904A1 (pt) |
| FI (1) | FI841897A (pt) |
| FR (1) | FR2546302B1 (pt) |
| GB (1) | GB2142030B (pt) |
| HU (1) | HU195004B (pt) |
| IL (1) | IL71802A0 (pt) |
| IT (1) | IT1175842B (pt) |
| LU (1) | LU85366A1 (pt) |
| NL (1) | NL8401616A (pt) |
| NO (1) | NO841993L (pt) |
| NZ (1) | NZ208108A (pt) |
| PL (1) | PL247745A1 (pt) |
| PT (1) | PT78610B (pt) |
| RO (1) | RO92427A (pt) |
| SE (1) | SE8402703L (pt) |
| YU (1) | YU86984A (pt) |
| ZA (1) | ZA843539B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6294172B1 (en) | 1983-08-12 | 2001-09-25 | Dade Behring Marburg Gmbh | Monoclonal antibodies with specificity for membrane-associated antigens |
| US4859581A (en) * | 1986-03-10 | 1989-08-22 | Board Of Regents, The University Of Texas System | Endoglycosidase assay |
| GB2209526B (en) * | 1987-09-04 | 1992-06-03 | Univ Washington | Dna clone of human type iv collagenase |
| US4923818A (en) * | 1987-09-04 | 1990-05-08 | Washington University | DNA clone of human type IV collagenase |
| US4876332A (en) * | 1987-10-08 | 1989-10-24 | Regents Of The Univeristy Of Minnesota | Polypeptides with type IV collagen activity |
| US5280106A (en) * | 1988-05-20 | 1994-01-18 | Liotta Lance A | Matrix metalloproteinase peptides: role in diagnosis and therapy |
| US5030555A (en) * | 1988-09-12 | 1991-07-09 | University Of Florida | Membrane-strip reagent serodiagnostic apparatus and method |
| DE3909799A1 (de) | 1989-03-24 | 1990-09-27 | Behringwerke Ag | Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung |
| US4992537A (en) * | 1989-05-15 | 1991-02-12 | Washington University | cDNA encoding 92-kDA type IV collagenase |
| ATE206129T1 (de) * | 1989-10-18 | 2001-10-15 | Us Health | Herstellung und verwendung des menschlichen nm23- h2-proteins und dagegen gerichtete antikörper |
| CA2074507A1 (en) * | 1990-01-26 | 1991-07-27 | William G. Stetler-Stevenson | Method for quantitatively measuring collagenase |
| WO1992020820A1 (en) * | 1991-05-15 | 1992-11-26 | Vanderbilt University | Method to determine metastatic potential of tumor cells |
| US5324634A (en) * | 1992-03-31 | 1994-06-28 | The Research Foundation Of State University Of New York | Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer |
| JP2673929B2 (ja) * | 1993-04-12 | 1997-11-05 | 富士薬品工業株式会社 | ヒト間質型コラゲナーゼと阻害剤との複合体の免疫学的定量法および臨床診断への応用 |
| ATE485888T1 (de) * | 2004-08-26 | 2010-11-15 | Life Technologies Corp | Elektrobenetzende abgabevorrichtungen und dazugehörige verfahren |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE343949B (pt) * | 1966-06-02 | 1972-03-20 | Pharmacia Ab | |
| DE2363854C3 (de) * | 1973-12-21 | 1980-01-03 | Behringwerke Ag, 3550 Marburg | Substrat zur Proteinasebestimmung sowie dessen Herstellung |
| US4201763A (en) * | 1975-10-09 | 1980-05-06 | Bio-Rad Laboratories, Inc. | Solid phase immunofluorescent assay method |
| DE3239410A1 (de) * | 1981-10-27 | 1983-05-19 | Hybritech Inc., 92121 San Diego, Calif. | Monoklonale antikoerper zu tumorassoziiertem antigen, zusammensetzungen, welche diese enthalten und deren anwendung zum tumornachweis |
| US4424278A (en) * | 1981-11-16 | 1984-01-03 | Research Corporation | Cancer detection procedure using an acyl carrier protein |
| US4443367A (en) * | 1982-04-08 | 1984-04-17 | Monsanto Company | Peptide and peptolide substrates for mammalian collagenase |
-
1983
- 1983-05-19 US US06/496,230 patent/US4677058A/en not_active Expired - Lifetime
-
1984
- 1984-05-09 NZ NZ208108A patent/NZ208108A/en unknown
- 1984-05-10 IL IL71802A patent/IL71802A0/xx unknown
- 1984-05-10 ZA ZA843539A patent/ZA843539B/xx unknown
- 1984-05-10 GB GB08411959A patent/GB2142030B/en not_active Expired
- 1984-05-11 CA CA000454194A patent/CA1230052A/en not_active Expired
- 1984-05-11 FI FI841897A patent/FI841897A/fi not_active Application Discontinuation
- 1984-05-15 BE BE0/212938A patent/BE899663A/fr not_active IP Right Cessation
- 1984-05-16 AU AU28087/84A patent/AU2808784A/en not_active Abandoned
- 1984-05-17 DK DK243184A patent/DK243184A/da not_active Application Discontinuation
- 1984-05-17 LU LU85366A patent/LU85366A1/fr unknown
- 1984-05-17 RO RO84114584A patent/RO92427A/ro unknown
- 1984-05-18 DE DE19843418625 patent/DE3418625A1/de not_active Withdrawn
- 1984-05-18 DD DD84263171A patent/DD251208A5/de unknown
- 1984-05-18 NL NL8401616A patent/NL8401616A/nl not_active Application Discontinuation
- 1984-05-18 PT PT78610A patent/PT78610B/pt unknown
- 1984-05-18 SE SE8402703A patent/SE8402703L/xx not_active Application Discontinuation
- 1984-05-18 HU HU841936A patent/HU195004B/hu unknown
- 1984-05-18 JP JP59101622A patent/JPS602187A/ja active Pending
- 1984-05-18 NO NO841993A patent/NO841993L/no unknown
- 1984-05-18 PL PL24774584A patent/PL247745A1/xx unknown
- 1984-05-18 CH CH2471/84A patent/CH668838A5/de not_active IP Right Cessation
- 1984-05-18 FR FR8407747A patent/FR2546302B1/fr not_active Expired
- 1984-05-18 ES ES532597A patent/ES8605904A1/es not_active Expired
- 1984-05-18 YU YU00869/84A patent/YU86984A/xx unknown
- 1984-05-18 IT IT20998/84A patent/IT1175842B/it active
Also Published As
| Publication number | Publication date |
|---|---|
| ES8605904A1 (es) | 1986-04-01 |
| GB8411959D0 (en) | 1984-06-13 |
| FR2546302B1 (fr) | 1988-03-04 |
| HU195004B (en) | 1988-03-28 |
| BE899663A (fr) | 1984-08-31 |
| FR2546302A1 (fr) | 1984-11-23 |
| CH668838A5 (de) | 1989-01-31 |
| PT78610B (en) | 1986-07-15 |
| PT78610A (en) | 1984-06-01 |
| IT8420998A0 (it) | 1984-05-18 |
| NZ208108A (en) | 1988-04-29 |
| GB2142030A (en) | 1985-01-09 |
| NL8401616A (nl) | 1984-12-17 |
| RO92427A (ro) | 1987-09-30 |
| PL247745A1 (en) | 1985-08-27 |
| ZA843539B (en) | 1985-07-31 |
| DD251208A5 (de) | 1987-11-04 |
| GB2142030B (en) | 1987-02-04 |
| HUT34261A (en) | 1985-02-28 |
| SE8402703L (sv) | 1984-11-20 |
| JPS602187A (ja) | 1985-01-08 |
| AU2808784A (en) | 1984-11-22 |
| IT8420998A1 (it) | 1985-11-18 |
| US4677058A (en) | 1987-06-30 |
| FI841897A (fi) | 1984-11-20 |
| IL71802A0 (en) | 1984-09-30 |
| IT1175842B (it) | 1987-07-15 |
| ES532597A0 (es) | 1986-04-01 |
| YU86984A (en) | 1991-01-28 |
| CA1230052A (en) | 1987-12-08 |
| DK243184D0 (da) | 1984-05-17 |
| DE3418625A1 (de) | 1984-11-22 |
| FI841897A0 (fi) | 1984-05-11 |
| DK243184A (da) | 1984-11-20 |
| SE8402703D0 (sv) | 1984-05-18 |
| LU85366A1 (fr) | 1984-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zamarron et al. | Monoclonal antibodies specific for a conformationally altered state of fibrinogen | |
| US5912158A (en) | Prostate specific antigen (PSA)-proteinase inhibitor complexes | |
| US4894326A (en) | Monoclonal antibody defining oncofetal structure of fibronectin | |
| Schuppan et al. | Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. Characterization and application to collagen type IV metabolism in fibrotic liver disease. | |
| NO841993L (no) | Immunologiske metoder for paavisning av maligne celler med metastatisk celleaktivitet, samt preparater for utfoerelse av slike metoder | |
| EP0741144B1 (en) | Antiannexin-v monoclonal antibody, process for producing the same, and use therof | |
| EP0344134A2 (en) | Monoclonal antibody specific to a fibronectin sequence expressed in transformed cells, hybridoma secreting said antibody and use of said monoclonal antibody in the diagnosis of tumors | |
| Scully et al. | AIDS-related Kaposi's sarcoma displays differential expression of endothelial surface antigens. | |
| ES2328306T3 (es) | Anticuerpo monospecifico reactivo con friginogeno y fibrinopeptido b. | |
| EP0421392A1 (en) | Anti-hCG-beta core monoclonal antibody, its production and use | |
| US7833726B2 (en) | Antibody for assaying ADAMTS13 activity and method for assaying the activity | |
| US4816400A (en) | Basement membrane collagen degrading enzyme and method of purifying same | |
| KR910008637B1 (ko) | 심근 미오신 중사슬에 대한 단일클론항체 | |
| US4808528A (en) | Antibody composition for the detection of malignant cells with metastatic cell activity | |
| Jemmerson et al. | Convenient selection of monoclonal antibodies to isoenzymes of placental alkaline phosphatase using the catalytic activity of the antigen in enzyme-antigen immunoassay | |
| US20080305499A1 (en) | Anti-Synoviolin Antibody | |
| Chinni et al. | Cathepsin D antigenic epitopes identified by the humoral responses of ovarian cancer patients | |
| US5635596A (en) | Peptides derived from the pS2 protein | |
| JPH0759588A (ja) | 増殖因子レセプターに対するモノクローナル抗体の製造方法及び抗ｃ−ｅｒｂＢ−２モノクローナル抗体 | |
| ITPD20000192A1 (it) | Anticorpi policlonali | |
| Itami et al. | Monoclonal antibodies to the β-andrenergic receptor: Modulation of catecholamine-sensitive adenylate cyclase by the antibody | |
| Kim et al. | Characterization of a monoclonal antibody that specifically inhibits pullulanase activity of Bacillus circulans amylase-pullulanase enzyme | |
| JP2005154389A (ja) | Ｃｄ４４の形態を識別する抗体 | |
| WO1996024065A1 (en) | Methods for the detection of pro-cathepsins and uses thereof | |
| JPH05317086A (ja) | カンジダ・アルビカンスの抗菌糸型抗体及び抗酵母型抗体 |